Lamictal Odt Trademark Details

Lamictal Odt was registered on Tuesday, September 22, 2009 and is currently owned by Glaxosmithkline LLC under the registration number 3687582 . This mark is alive with a status of Section 8 & 15-Accepted and Acknowledged. The last case file activity for this mark occured 8 years ago on Friday, September 4, 2015, according to the United State Patent & Trademark Office
Word Mark Lamictal Odt
Status Alive Registered 702 — Section 8 & 15-Accepted and Acknowledged

Current Owner

Glaxosmithkline LLC of Wilmington, DE

View all trademarks for Glaxosmithkline LLC
Other Trademarks for Glaxosmithkline LLC

Previous Owners

Smithkline Beecham Corporation of Philadelphia, PA

View all trademarks for Smithkline Beecham Corporation
Other Trademarks for Smithkline Beecham Corporation
Serial Number 78822402
Registration Number 3687582
Status Date Friday, September 4, 2015
Filing Date Friday, September 4, 2015
Registration Date Tuesday, September 22, 2009
Attorney Diane Fry Maginnis
Domestic Representative Maribeth Day Case

Correspondent

Diane Fry Maginnis
GlaxoSmithKline
Five Moore Drive
LGTM, C.3157.3D
Research Triangle Park NC 27709

Case File Statements

Disclaimer with Predetermined Text "Odt"
Goods & Services Pharmaceutical Preparations and Substances for the Treatment of Neurological and Psychiatric Related Diseases and Disorders

Classifications

International Class Codes
005 — Class 5 includes mainly pharmaceuticals and other preparations for medical or veterinary purposes.
U.S. Class Codes 006, 018, 044, 046, 051, 052
Status 6 — Active
Status Date Thursday, March 2, 2006
First Use Anywhere Friday, June 5, 2009
First Use In Commerce Friday, June 5, 2009
Primary Code 005

You must be signed in to print.

Once signed in, look for the PDF button.